The Effect of Rituximab on the Development of Anti-Donor Antibodies

NCT00695097 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Renal Transplant Rejection

Interventions

DRUG: Rituximab
DRUG: No Rituximab

Sponsor

University of California, San Francisco

Collaborators

[object Object]